Masataka Oda
Takamatsu, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Enzymatic polyethylene terephthalate degradation using a genetically stabilized cutinase immobilized on magnetic nanoparticles.
Journal: Journal of environmental management
Published: April 22, 2025
Oral and transdermal administration of lipopolysaccharide safely enhances self-healing ability through the macrophage network.
Journal: Frontiers in immunology
Published: January 20, 2025
Restoration of Spatial Learning Through Oral Administration of Lipopolysaccharides in Diabetes-related Cognitive Dysfunction.
Journal: In vivo (Athens, Greece)
Published: May 02, 2024
Development of a Water Soluble Self-assembling Analogue of Vizantin.
Journal: Chemical & pharmaceutical bulletin
Published: February 28, 2024
Maintenance of homeostasis by TLR4 ligands.
Journal: Frontiers in immunology
Published: August 31, 2023
Oral Administration of Lipopolysaccharide Enhances Insulin Signaling-Related Factors in the KK/Ay Mouse Model of Type 2 Diabetes Mellitus.
Journal: International journal of molecular sciences
Published: January 31, 2023
Effects of Erythromycin on Osteoclasts and Bone Resorption via DEL-1 Induction in Mice.
Journal: Antibiotics (Basel, Switzerland)
Published: February 01, 2021
Sulfated vizantin causes detachment of biofilms composed mainly of the genus Streptococcus without affecting bacterial growth and viability.
Journal: BMC microbiology
Published: April 29, 2020
Role of Sphingomyelinase in the Pathogenesis of Bacillus cereus Infection.
Journal: Biological & pharmaceutical bulletin
Published: February 04, 2020
Erythromycin inhibits neutrophilic inflammation and mucosal disease by upregulating DEL-1.
Journal: JCI insight
Published: January 24, 2020
Last Updated: 09/26/2026